Figure 5
From: Pan-cancer analysis reveals IGFL2 as a potential target for cancer prognosis and immunotherapy
Correlation of scores, TMB and MSI and LCN2 expression in cancer. (A) Correlation of ImmuneScore, StromalScore and ESTIMATEScore with IGFL2 expression in COAD,LUSC,THCA. (B) Correlation of IGFL2 with TMB,MSI. ***p < 0.001 **p < 0.01 *p < 0.05.
